LUCD Stock Analysis: Buy, Sell, or Hold?
LUCD - Lucid Diagnostics Inc. Common Stock
$0.96
-0.02 (-1.78%)
▼
5d:
-0.67%
30d:
-5.81%
90d:
-29.88%
BUY
HIGH Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: May 15, 2026
0d
Get Alerted When LUCD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: LUCD shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: LUCD shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: LUCD is currently trading at $0.96, which is considered oversold relative to its 30-day fair value range of $0.98 to $1.05.
Technical Outlook: Technically, LUCD is in a strong downtrend. The price is currently testing key support at $0.95. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.95 (+311.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LUCD is in a strong downtrend. The price is currently testing key support at $0.95. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.95 (+311.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.98 -
$1.05
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 311.2% below Wall St target ($3.95)
Trading Range Analysis
30-Day Trading Range
$0.98 -
$1.05
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.95
Resistance Level
$1.10
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.65
Wall Street Target
$3.95
(+311.2%)
Revenue Growth (YoY)
51.7%
Share & Embed Analysis
Last updated: June 14, 2026 9:20 AM ET
Data refreshes hourly during market hours. Next update: 10:20 AM
Data refreshes hourly during market hours. Next update: 10:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LUCD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 68 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 60 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 55 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$99 | 60 HOLD |
